4 new cases of COVID-19 out of 585 tested; CAR score 0.1

346

Four new cases of COVID-19 were identified out of 585 tests performed by the Department of Public Health and Social Services (DPHSS) on Sunday, March 21, and tests from additional labs from Friday, March 19 to Sunday, March 21. One (1) case reported recent travel history and was identified in quarantine.

To date, there have been a total of 7,784 officially reported cases of COVID-19 with 134 deaths, 27 cases in active isolation, and 7,623 not in active isolation.

TODAY’S CAR SCORE

0.1

The COVID Area Risk (CAR) Score accounts for the incidence of new cases, how well current testing identifies these cases, and the rate of spread. The ideal long-term goal is to sustain a CAR Score of 2.5 or less, which has been shown to correlate with very low to zero COVID-related hospitalizations and deaths.

The following tables provide COVID-19 test results reported to the JIC on Monday, March 22,

and reflects results additional labs from Friday, March 19 to Sunday, March 21:

COVID-19 CASE COUNT

TOTAL

NEW CASES REPORTED TODAY

PAST 7 DAYS

COVID-19 CASES:

7,784

4

11

CONFIRMED CASES:

7,574

4

11

PROBABLE CASES:

210

0

0

 

COVID-19 TESTING

ON GUAM

TOTAL

NEW TESTS

REPORTED TODAY

7-DAY

% POSITIVE

DIAGNOSTIC TESTS

137,351

585

0.5%

MOLECULAR TESTS

127,351

482

0.6%

ANTIGEN TEST

10,000

103

0%

SEROLOGY TESTS

362

1

50%

 

CASE BREAKDOWN

STATUS

TOTAL

CURRENT ISOLATION LOCATION

TOTAL

COVID-19 Death

134

Hospital

1

Active Isolation

27

Home

13

Not In Isolation

7,623

Isolation Facility

7

Civilian

7,387

Military

6

Military Service Member

397

 

COVID HOSPITAL CENSUS

Guam Memorial Hospital

Guam Regional Medical City

U.S. Naval Hospital

TOTAL

COVID ADMISSION

1

0

0

1

IN ICU

0

0

0

0

ON VENTILATOR

0

0

0

0

 

The following provides preliminary COVID-19 vaccinations reported to the JIC on Monday, March 22, for vaccinations administered from December 17 to March 21:

Vaccine Maker

1st Doses Administered

2nd Doses Administered

Total Doses Administered

Individuals Fully Immunized

Pfizer-BioNTech

23,875

16,162*

40,037

16,162

Moderna

16,700**

14,548***

31,248

14,548

Johnson & Johnson Janssen

25****

25****

TOTALS:

40,575

30,710

71,310^

30,735

*Administering second doses of Pfizer-BioNTech COVID-19 vaccinations began on January 4, 2021.

**Administering first doses of Moderna COVID-19 vaccinations began on January 8, 2021.

***Administering second doses of Moderna COVID-19 vaccinations began on January 29, 2021.

****Johnson &Johnson/Janssen COVID-19 vaccinations began on March 15 and were developed as a one-dose series.

 

Total Doses Administered

Total Doses Allotted

% Administered

Doses Remaining

71,310^

87,860^^

81.16%

16,550

^As of March 21, 2021. Total doses administered and allotted doses differ as vaccinators were able to draw additional doses per vial. Additionally, the U.S. Food and Drug Administration’s February 25, 2021 revision of their Fact Sheet relative to the Pfizer-BioNTech Emergency Use Authorization now states, “After dilution, one vial contains six doses of 0.3 mL. Vial labels and cartons may state that after dilution, a vial contains five doses of 0.3 mL. The information in this Fact Sheet regarding the number of doses per vial after dilution supersedes the number of doses stated on vial labels and cartons.” | ^^Reflects the previous allocation total of 86,560 and last received an allocation of 1,300 Johnson & Johnson Janssen vaccines on March 8, 2021.

(JIC Release No. 610)

##